Opportunities and risk report

The Fresenius Group will continue to take advantage of the wide-ranging opportunities for sustainable growth and expansion that the healthcare market offers. Fresenius comprises the Operating Companies Fresenius Kabi and Fresenius Helios as well as the remaining activities of Fresenius Vamed, which have been renamed to VIACAMA. All Operating Companies are market leaders in growth areas of the healthcare sector.

At the same time, the Fresenius Group is exposed to several risks due to the complexity and the dynamics of its business. These risks are inevitable consequences of entrepreneurial activity because opportunities can only be exploited when there is a willingness to take risks.

Many years of experience, as well as a regularly leading market position, serve as a solid basis for achieving a realistic assessment of opportunities and risks.